{"abstract":"The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, in cosponsorship with the National Organization for Rare Disorders (NORD), is announcing a 1-day public workshop entitled \"Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction.\" Partners and stakeholders planning the workshop also include representatives from academia, industry, and patients. The purpose of this workshop is to provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products.","action":"Notice of public workshop.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/05/13/2014-10933.html","cfr_references":[],"citation":"79 FR 27313","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The public workshop will be held on June 9, 2014, from 8 a.m. to 5 p.m.","disposition_notes":null,"docket_ids":["Docket No. FDA-2014-N-0001"],"dockets":[],"document_number":"2014-10933","effective_on":null,"end_page":27313,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/05/13/2014-10933.xml","html_url":"https://www.federalregister.gov/documents/2014/05/13/2014-10933/immune-responses-to-enzyme-replacement-therapies-role-of-immune-tolerance-induction-public-workshop","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-10933?publication_date=2014-05-13","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-05-13/2014-10933/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":271,"last_updated":"2026-04-04 18:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-05-13/pdf/2014-10933.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-10933.pdf?1399899295","publication_date":"2014-05-13","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/05/13/2014-10933.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2014-06-02T06:00:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":27313,"subtype":null,"title":"Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction; Public Workshop","toc_doc":"Immune Responses to Enzyme Replacement Therapies, Role of Immune Tolerance Induction; Workshop","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}